Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

EFLM Task Grp Cardiac Markers; Angelika Hammerer-Lercher; Damien Gruson; Janne Suvisaari; Kari Pulkki; Päivi Laitinen

doi:10.1016/j.cca.2020.09.030

Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

EFLM Task Grp Cardiac Markers, Angelika Hammerer-Lercher, Damien Gruson, Janne Suvisaari, Kari Pulkki, Päivi Laitinen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Clinica Chimica Acta
Volym	511
Sidor (från-till)	59-66
Antal sidor	8
ISSN	0009-8981
DOI	https://doi.org/10.1016/j.cca.2020.09.030
Status	Publicerad - dec 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3111 Biomedicinska vetenskaper

Åtkomst av dokument

10.1016/j.cca.2020.09.030

Citera det här

EFLM Task Grp Cardiac Markers, Hammerer-Lercher, A., Gruson, D., Suvisaari, J., Pulkki, K., & Laitinen, P. (2020). Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study. Clinica Chimica Acta, 511, 59-66. https://doi.org/10.1016/j.cca.2020.09.030

EFLM Task Grp Cardiac Markers ; Hammerer-Lercher, Angelika ; Gruson, Damien ; Suvisaari, Janne ; Pulkki, Kari ; Laitinen, Päivi. / Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study. I: Clinica Chimica Acta. 2020 ; Vol. 511. s. 59-66.

@article{83ab9a366a994db3a336f54b31c9bd21,

title = "Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study",

keywords = "Guideline implementation, Heart failure, B-type natriuretic peptide, N-terminal B-type natriuretic peptide, Biomarkers, follow-up, Laboratory practice, 3111 Biomedicine",

author = "{EFLM Task Grp Cardiac Markers} and Angelika Hammerer-Lercher and Damien Gruson and Sanja Stankovic and Paul Collinson and Janne Suvisaari and Kari Pulkki and Duff, {Christopher J.} and Hannsjoerg Baum and Ana Stavljenic-Rukavina and Aakre, {Kristin M.} and Langlois, {Michel R.} and P{\"a}ivi Laitinen",

year = "2020",

month = dec,

doi = "10.1016/j.cca.2020.09.030",

language = "English",

volume = "511",

pages = "59--66",

journal = "Clinica Chimica Acta",

issn = "0009-8981",

publisher = "Elsevier Scientific Publ. Co",

}

EFLM Task Grp Cardiac Markers, Hammerer-Lercher, A, Gruson, D, Suvisaari, J , Pulkki, K & Laitinen, P 2020, 'Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study', Clinica Chimica Acta, vol. 511, s. 59-66. https://doi.org/10.1016/j.cca.2020.09.030

Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study. / EFLM Task Grp Cardiac Markers; Hammerer-Lercher, Angelika; Gruson, Damien; Suvisaari, Janne ; Pulkki, Kari ; Laitinen, Päivi.

I: Clinica Chimica Acta, Vol. 511, 12.2020, s. 59-66.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

AU - EFLM Task Grp Cardiac Markers

AU - Hammerer-Lercher, Angelika

AU - Gruson, Damien

AU - Stankovic, Sanja

AU - Collinson, Paul

AU - Suvisaari, Janne

AU - Pulkki, Kari

AU - Duff, Christopher J.

AU - Baum, Hannsjoerg

AU - Stavljenic-Rukavina, Ana

AU - Aakre, Kristin M.

AU - Langlois, Michel R.

AU - Laitinen, Päivi

PY - 2020/12

Y1 - 2020/12

KW - Guideline implementation

KW - Heart failure

KW - B-type natriuretic peptide

KW - N-terminal B-type natriuretic peptide

KW - Biomarkers, follow-up

KW - Laboratory practice

KW - 3111 Biomedicine

U2 - 10.1016/j.cca.2020.09.030

DO - 10.1016/j.cca.2020.09.030

M3 - Article

VL - 511

SP - 59

EP - 66

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -

EFLM Task Grp Cardiac Markers, Hammerer-Lercher A, Gruson D, Suvisaari J , Pulkki K , Laitinen P. Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study. Clinica Chimica Acta. 2020 dec;511:59-66. https://doi.org/10.1016/j.cca.2020.09.030